“Studies Demonstrate Use of Gentian Calprotectin Test to Triage COVID-19 Patients”

28. Jan 2021 | 4 min read

“Studies Demonstrate Use of Gentian Calprotectin Test to Triage COVID-19 Patients”

Gentian has together with research partners presented two posters related to the value of plasma and serum calprotectin in the management of COVID-19 patients at the AACC 2020. The results presented at the AACC conference show elevated levels of calprotectin in plasma/serum in patients with severe form of COVID-19. This suggests that calprotectin can be a valuable biomarker for prediction of mortality and need for mechanical ventilation. Both studies have used Gentian’s calprotectin immunoassay GCAL® for measurement of calprotectin in plasma and serum.

 

GCAL® to triage COVID-19 patients and PETIA benefits

360Dx, a dedicated newsroom that covers emerging economic and technological trends in the clinical diagnostic market, has caught interest in the utility of calprotectin as a tool for risk assessment and prediction of clinical deterioration in COVID-19 patients.

360Dx has recently published an article that focuses on the recent results from the two AACC posters, confirming the value of calprotectin in severe COVID-19 disease. In the same article they also emphasises GCAL® 's (Gentian’s plasma and serum calprotectin assay) advantages being a particle-enhanced turbidimetric immunoassay (PETIA), compared to conventional enzyme-linked immunosorbent assays (ELISA).

Read the full article Studies Demonstrate Use of Gentian Calprotectin Test to Triage COVID-19 Patients with information from the two poster and more insights from Gentian's VP Clinical Affairs, Dr. Aleksandra Mandic Havelka and one of the co-author of one of the posters Dr. Luis García de Guadiana-Romualdo from the Hospital Universitario Santa Lucía in Cartagena, Spain.

 

 

Contact us for more information

Do you want to know more about our calprotectin and COVID-19 or our GCAL®  Immunoassay? If yes, please fill out the form below or send an email to marketing@gentian.com and our Product Manager for GCAL® will contact you shortly.

 

You may also read


Gentian showcases diagnostic research at EuroMedLab 2025

May 20, 2025

Gentian showcases diagnostic research at EuroMedLab 2025

Posters: Retinol-Binding Protein and NT-proBNP At EuroMedLab 2025 in Brussels, Gentian Diagnostics will..

Canine CRP assay at EuroMedLab 2025

May 14, 2025

Canine CRP assay at EuroMedLab 2025

Learn more about Gentian's turbidimetric canine CRP assay at booth #115 Gentian Diagnostics will also this..

Gentian @ EuroMedLab 2025: Raising the standard in inflammation testing with GCAL®

May 12, 2025

Gentian @ EuroMedLab 2025: Raising the standard in inflammation testing with GCAL®

GCAL® Calprotectin – A new standard in inflammation testing At EuroMedLab 2025 in Brussels, Gentian..